News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemagen Diagnostics, Inc. (HMGN) Reports First Quarter Financial Results


10/19/2005 5:12:44 PM

COLUMBIA, Md.--(BUSINESS WIRE)--Feb. 15, 2005--Hemagen Diagnostics, Inc. (OTCBB:HMGN.OB) a biotechnology company that develops, manufactures, and markets proprietary medical diagnostic test kits, today reported operating results for the first fiscal quarter ended December 31, 2004. For the three-month period ended December 31, 2004, the net loss was $235,000 or $(0.02) per share, compared to a net loss of $574,000 or ($0.06) per share for the period ended December 31, 2003. After adjusting for non-cash charges including depreciation, amortization, and non-cash interest, the net loss for the quarter ended December 31, 2004 was $103,000 compared to a net loss of $68,000 for the quarter ended December 31, 2003.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES